Abstract
There is clearly a need to identify reliable endpoints in cancer prevention trials [(1)][1] . However, the limitations of the adenoma-carcinoma model in the colorectum are underappreciated. The fact that colorectal adenomas may progress to cancer is beyond dispute. Far less clear is the proportion
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical cancer research : an official journal of the American Association for Cancer Research
Paper Title
Journal
Date
